Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VALSARTAN Cause Prostatic specific antigen increased? 22 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Prostatic specific antigen increased have been filed in association with VALSARTAN (valsartan). This represents 0.1% of all adverse event reports for VALSARTAN.

22
Reports of Prostatic specific antigen increased with VALSARTAN
0.1%
of all VALSARTAN reports
0
Deaths
15
Hospitalizations

How Dangerous Is Prostatic specific antigen increased From VALSARTAN?

Of the 22 reports, 15 (68.2%) required hospitalization, and 5 (22.7%) were considered life-threatening.

Is Prostatic specific antigen increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 22 reports have been filed with the FAERS database.

What Other Side Effects Does VALSARTAN Cause?

Drug ineffective (1,845) Blood pressure increased (1,682) Dizziness (1,527) Headache (1,361) Hypertension (1,341) Acute kidney injury (1,301) Dyspnoea (1,239) Fatigue (1,156) Malaise (1,139) Hypotension (1,032)

What Other Drugs Cause Prostatic specific antigen increased?

ENZALUTAMIDE (3,731) LEUPROLIDE (2,432) ABIRATERONE (1,581) RADIUM RA-223 DICHLORIDE (449) RELUGOLIX (335) BICALUTAMIDE (322) DOCETAXEL (282) APALUTAMIDE (251) DENOSUMAB (220) LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)

Which VALSARTAN Alternatives Have Lower Prostatic specific antigen increased Risk?

VALSARTAN vs VALTREX VALSARTAN vs VAMOROLONE VALSARTAN vs VANCOMYCIN VALSARTAN vs VANDETANIB VALSARTAN vs VARDENAFIL

Related Pages

VALSARTAN Full Profile All Prostatic specific antigen increased Reports All Drugs Causing Prostatic specific antigen increased VALSARTAN Demographics